Sooma Oy is a Finnish medical device company developing non-invasive brain stimulation devices for treatment of neurological and psychiatric disorders. Since it’s establishment in 2013, Sooma has been working closely with leading experts in psychiatry and clinical neurophysiology to provide better care for all of us.
Sooma tDCS, a low threshold therapy solution for major depressive disorder, was launched at the end of 2014. The treatment is safe, effective, well tolerated and suitable for most people.
Our products are designed and manufactured using internationally-accepted standards of performance. Sooma Oy is ISO 13485 certified (medical device standard). Sooma has also achieved ISO 9001 Quality Certification.
In the EU, our products are CE-marked as medical devices according to the Medical device directive 93/42/EEC. Our manufacturing is located in Finland.
All Sooma products are CE-marked as medical devices or medical device accessories. Medical device CE-marking ensures that the products are safe to use in patient work and also effective within their indication of use.
Sooma Ltd is committed to provide neurological therapy devices and services that meet customer and regulatory requirements by maintaining an effective quality management system.